Annual EBIT
-$169.18 M
+$56.77 M+25.12%
31 December 2023
Summary:
Editas Medicine annual earnings before interest & taxes is currently -$169.18 million, with the most recent change of +$56.77 million (+25.12%) on 31 December 2023. During the last 3 years, it has fallen by -$34.34 million (-25.47%). EDIT annual EBIT is now -1139.33% below its all-time high of -$13.49 million.EDIT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$65.67 M
+$6.24 M+8.67%
30 September 2024
Summary:
Editas Medicine quarterly earnings before interest & taxes is currently -$65.67 million, with the most recent change of +$6.24 million (+8.67%) on 30 September 2024. Over the past year, it has dropped by -$15.50 million (-30.91%). EDIT quarterly EBIT is now -830.52% below its all-time high of $8.99 million, reached on 30 September 2020.EDIT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$228.52 M
-$15.50 M-7.28%
30 September 2024
Summary:
Editas Medicine TTM earnings before interest & taxes is currently -$228.52 million, with the most recent change of -$15.50 million (-7.28%) on 30 September 2024. Over the past year, it has dropped by -$19.86 million (-9.52%). EDIT TTM EBIT is now -4136.60% below its all-time high of -$5.39 million, reached on 31 December 2014.EDIT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.1% | -30.9% | -9.5% |
| 3 y3 years | -25.5% | -67.3% | -5.1% |
| 5 y5 years | -48.8% | -89.8% | -78.9% |
EDIT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.5% | +25.1% | -174.0% | +8.7% | -35.1% | at low |
| 5 y | 5 years | -48.8% | +25.1% | -830.5% | +8.7% | -110.8% | at low |
| alltime | all time | -1139.3% | +25.1% | -830.5% | +8.7% | -4136.6% | at low |
Editas Medicine EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$65.67 M(-8.7%) | -$228.52 M(+7.3%) |
| June 2024 | - | -$71.90 M(+7.3%) | -$213.02 M(+15.0%) |
| Mar 2024 | - | -$66.99 M(+179.6%) | -$185.21 M(+9.5%) |
| Dec 2023 | -$169.18 M(-25.1%) | -$23.96 M(-52.2%) | -$169.18 M(-18.9%) |
| Sept 2023 | - | -$50.16 M(+13.8%) | -$208.66 M(-3.4%) |
| June 2023 | - | -$44.09 M(-13.5%) | -$216.02 M(-4.5%) |
| Mar 2023 | - | -$50.96 M(-19.7%) | -$226.16 M(+0.1%) |
| Dec 2022 | -$225.95 M(+17.0%) | -$63.45 M(+10.3%) | -$225.95 M(+10.7%) |
| Sept 2022 | - | -$57.52 M(+6.1%) | -$204.11 M(+9.8%) |
| June 2022 | - | -$54.23 M(+6.9%) | -$185.85 M(-0.6%) |
| Mar 2022 | - | -$50.75 M(+22.0%) | -$187.01 M(-3.2%) |
| Dec 2021 | -$193.15 M(+43.2%) | -$41.61 M(+6.0%) | -$193.15 M(-11.2%) |
| Sept 2021 | - | -$39.25 M(-29.1%) | -$217.41 M(+28.5%) |
| June 2021 | - | -$55.40 M(-2.6%) | -$169.17 M(+16.6%) |
| Mar 2021 | - | -$56.88 M(-13.6%) | -$145.10 M(+7.6%) |
| Dec 2020 | -$134.84 M(-4.3%) | -$65.87 M(-832.8%) | -$134.84 M(+24.4%) |
| Sept 2020 | - | $8.99 M(-128.7%) | -$108.39 M(-28.7%) |
| June 2020 | - | -$31.34 M(-32.8%) | -$151.97 M(-2.8%) |
| Mar 2020 | - | -$46.62 M(+18.2%) | -$156.28 M(+10.9%) |
| Dec 2019 | -$140.92 M | -$39.42 M(+14.0%) | -$140.92 M(+10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$34.59 M(-3.0%) | -$127.75 M(+16.8%) |
| June 2019 | - | -$35.65 M(+14.0%) | -$109.42 M(-3.5%) |
| Mar 2019 | - | -$31.26 M(+19.1%) | -$113.43 M(-0.3%) |
| Dec 2018 | -$113.73 M(-4.7%) | -$26.25 M(+61.5%) | -$113.73 M(-7.8%) |
| Sept 2018 | - | -$16.26 M(-59.0%) | -$123.33 M(-7.8%) |
| June 2018 | - | -$39.66 M(+25.7%) | -$133.82 M(+11.3%) |
| Mar 2018 | - | -$31.56 M(-12.0%) | -$120.28 M(+0.8%) |
| Dec 2017 | -$119.35 M(+22.7%) | -$35.85 M(+34.0%) | -$119.35 M(-2.6%) |
| Sept 2017 | - | -$26.75 M(+2.4%) | -$122.53 M(+4.8%) |
| June 2017 | - | -$26.11 M(-14.7%) | -$116.95 M(+6.3%) |
| Mar 2017 | - | -$30.63 M(-21.6%) | -$110.03 M(+13.2%) |
| Dec 2016 | -$97.25 M(+33.7%) | -$39.04 M(+84.5%) | -$97.25 M(-10.0%) |
| Sept 2016 | - | -$21.16 M(+10.2%) | -$108.02 M(+14.6%) |
| June 2016 | - | -$19.20 M(+7.6%) | -$94.24 M(+10.3%) |
| Mar 2016 | - | -$17.84 M(-64.2%) | -$85.44 M(+17.3%) |
| Dec 2015 | -$72.76 M(+433.0%) | -$49.82 M(+574.9%) | -$72.86 M(+156.2%) |
| Sept 2015 | - | -$7.38 M(-29.0%) | -$28.43 M(+35.1%) |
| June 2015 | - | -$10.40 M(+97.6%) | -$21.05 M(+97.6%) |
| Mar 2015 | - | -$5.26 M(-2.5%) | -$10.65 M(+97.5%) |
| Dec 2014 | -$13.65 M | -$5.39 M | -$5.39 M |
FAQ
- What is Editas Medicine annual earnings before interest & taxes?
- What is the all time high annual EBIT for Editas Medicine?
- What is Editas Medicine annual EBIT year-on-year change?
- What is Editas Medicine quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Editas Medicine?
- What is Editas Medicine quarterly EBIT year-on-year change?
- What is Editas Medicine TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Editas Medicine?
- What is Editas Medicine TTM EBIT year-on-year change?
What is Editas Medicine annual earnings before interest & taxes?
The current annual EBIT of EDIT is -$169.18 M
What is the all time high annual EBIT for Editas Medicine?
Editas Medicine all-time high annual earnings before interest & taxes is -$13.49 M
What is Editas Medicine annual EBIT year-on-year change?
Over the past year, EDIT annual earnings before interest & taxes has changed by +$56.77 M (+25.12%)
What is Editas Medicine quarterly earnings before interest & taxes?
The current quarterly EBIT of EDIT is -$65.67 M
What is the all time high quarterly EBIT for Editas Medicine?
Editas Medicine all-time high quarterly earnings before interest & taxes is $8.99 M
What is Editas Medicine quarterly EBIT year-on-year change?
Over the past year, EDIT quarterly earnings before interest & taxes has changed by -$15.50 M (-30.91%)
What is Editas Medicine TTM earnings before interest & taxes?
The current TTM EBIT of EDIT is -$228.52 M
What is the all time high TTM EBIT for Editas Medicine?
Editas Medicine all-time high TTM earnings before interest & taxes is -$5.39 M
What is Editas Medicine TTM EBIT year-on-year change?
Over the past year, EDIT TTM earnings before interest & taxes has changed by -$19.86 M (-9.52%)